Prosecution Insights
Last updated: April 19, 2026

Examiner: BEKELE, MEKONEN T

Tech Center 2600 • Art Units: 2624 2666 2699

This examiner grants 79% of resolved cases

Performance Statistics

79.1%
Allow Rate
+17.1% vs TC avg
780
Total Applications
+13.1%
Interview Lift
1077
Avg Prosecution Days
Based on 757 resolved cases, 2023–2026

Rejection Statute Breakdown

12.8%
§101 Eligibility
27.5%
§102 Novelty
42.2%
§103 Obviousness
9.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18648212 METHOD AND DEVICE WITH DETERMINING POSE OF TARGET OBJECT IN QUERY IMAGE Non-Final OA Samsung Electronics Co., Ltd.
18518787 ELECTRONIC DEVICE PERFORMING SCALING USING ARTIFICIAL INTELLIGENCE MODEL AND METHOD FOR OPERATING THE SAME Non-Final OA Samsung Electronics Co., Ltd.
18409893 IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND STORAGE MEDIUM Non-Final OA NEC Corporation
18610221 IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, AND PROGRAM Non-Final OA FUJIFILM Corporation
18701575 Method and Apparatus Non-Final OA Oxa Autonomy Ltd
18551658 MASKING UNWANTED PIXELS IN AN IMAGE Final Rejection KONINKLIJKE PHILIPS N.V.
18217409 ENHANCED VISION PROCESSING AND SENSOR SYSTEM FOR AUTONOMOUS VEHICLE Non-Final OA Tesla, Inc.
18352828 EDGE ENHANCEMENT FOR SKY REPLACEMENT Final Rejection Adobe Inc.
18190512 SYSTEMS, DEVICES, AND METHODS FOR RECOGNIZING DEFECTS IN MEDICAL GRAFT PROCESSING Final Rejection Coloplast A/S
18456465 SYSTEMS AND METHODS FOR DENOISING MEDICAL IMAGES Final Rejection UNIVERSITY OF SOUTH FLORIDA
18661246 SYSTEMS AND METHODS FOR PREPARING CORNEAL TISSUE FOR IMPLANT Non-Final OA CorneaGen
18627691 SYSTEMS AND METHODS FOR FACILITATING LESION INSPECTION AND ANALYSIS Non-Final OA EXINI Diagnostics AB
18345275 OPHTHALMOLOGIC IMAGE PROCESSING SYSTEM, OPHTHALMOLOGIC IMAGE PROCESSING DEVICE, AND STORAGE MEDIUM FOR STORING OPHTHALMOLOGIC IMAGE PROCESSING PROGRAM Final Rejection NIDEK CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month